- Home
- XENE vs BOH Comparison
XENE vs BOH Comparison
Compare XENE & BOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- BOH
- Stock Information
- Founded
- XENE 1996
- BOH 1897
- Country
- XENE Canada
- BOH United States
- Employees
- XENE N/A
- BOH N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- BOH Major Banks
- Sector
- XENE Health Care
- BOH Finance
- Exchange
- XENE Nasdaq
- BOH Nasdaq
- Market Cap
- XENE 2.4B
- BOH 2.6B
- IPO Year
- XENE 2014
- BOH N/A
- Fundamental
- Price
- XENE $39.21
- BOH $68.33
- Analyst Decision
- XENE Strong Buy
- BOH Hold
- Analyst Count
- XENE 11
- BOH 6
- Target Price
- XENE $52.73
- BOH $72.33
- AVG Volume (30 Days)
- XENE 833.8K
- BOH 356.5K
- Earning Date
- XENE 08-11-2025
- BOH 10-27-2025
- Dividend Yield
- XENE N/A
- BOH 4.07%
- EPS Growth
- XENE N/A
- BOH 7.02
- EPS
- XENE N/A
- BOH 3.81
- Revenue
- XENE $7,500,000.00
- BOH $657,046,000.00
- Revenue This Year
- XENE N/A
- BOH $14.47
- Revenue Next Year
- XENE $256.34
- BOH $7.03
- P/E Ratio
- XENE N/A
- BOH $18.07
- Revenue Growth
- XENE N/A
- BOH 3.70
- 52 Week Low
- XENE $26.74
- BOH $57.45
- 52 Week High
- XENE $46.00
- BOH $82.70
- Technical
- Relative Strength Index (RSI)
- XENE 67.80
- BOH 57.46
- Support Level
- XENE $38.13
- BOH $66.58
- Resistance Level
- XENE $39.84
- BOH $69.20
- Average True Range (ATR)
- XENE 0.99
- BOH 1.25
- MACD
- XENE -0.09
- BOH 0.21
- Stochastic Oscillator
- XENE 77.70
- BOH 66.79
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About BOH Bank of Hawaii Corporation
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.